(2026)
Prognostic Value of Pseudotime from Texture Parameters of [18F] fluorodeoxyglucose PET/CT in Resectable Pancreatic Ductal Adenocarcinoma.
ACADEMIC RADIOLOGY.
33,
1
(2025)
First Real-World Evidence on the Safety and Effectiveness of Lutathera™ for Treating Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Insights from Post-Marketing Surveillance.
CANCERS.
17,
18
(2025)
Synthetic data generation method improves risk prediction model for early tumor recurrence after surgery in patients with pancreatic cancer.
SCIENTIFIC REPORTS.
15,
1
(2025)
Artificial Delayed-phase Technetium-99m MIBI Scintigraphy From Early-phase Scintigraphy Improves Identification of Hyperfunctioning Parathyroid Lesions in Patients With Hyperparathyroidism.
CLINICAL NUCLEAR MEDICINE.
50,
7
(2025)
18F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
ANTICANCER RESEARCH.
45,
3
(2024)
Prognostic value of pseudotime from texture parameters of FDG PET/CT in locally advanced rectal cancer with neoadjuvant concurrent chemoradiotherapy.
SCIENTIFIC REPORTS.
14,
1
(2024)
Prognostic Significance of 18F-FDG PET/CT Radiomics in Patients With Resectable Pancreatic Ductal Adenocarcinoma Undergoing Curative Surgery.
CLINICAL NUCLEAR MEDICINE.
49,
10
(2023)
Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation.
CANCER IMAGING.
23,
1
(2023)
A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer.
CANCERS.
15,
15
(2023)
A Machine Learning Approach Using [18F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor.
MOLECULAR IMAGING AND BIOLOGY.
25,
5
(2023)
Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis.
SCIENTIFIC REPORTS.
13,
1
(2022)
A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer.
ANTICANCER RESEARCH.
42,
12
(2022)
The Role of Preoperative F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma.
FRONTIERS IN ONCOLOGY.
12,
학술회의논문
(2025)
Clinical Significance of Grade 1 Cardiac Uptake on Tc-99m DPD scan with SPECT/CT in patients with Suspicion of Cardiac Amyloidosis.
2025 Annual Meeting of KSNM & ARCCNM.
대한민국
(2025)
Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ductal Adenocarcinoma.
2025 Annual Meeting of KSNM & ARCCNM.
대한민국
(2025)
A Prospective Study Comparing FP-CIT PET Features in RBD and Normal Individuals.
2025 SNMMI Annual Meeting.
미국
(2024)
A Prospective Study Comparing FP-CIT PET Features in RBD and Normal Individuals.
Annual Meeting of KSNM & ARCCNM.
대한민국
(2024)
Diagnostic Value of 18F-Fluorodeoxyglucose PET/CT in Surveillance after Curative Therapy of Head and Neck Squamous Cell Carcinoma.
Annual Meeting of KSNM & ARCCNM.
대한민국
(2023)
Correlation between Tumor FDG uptake and pathologic features in hepatocellular carcinoma.
Annual Meeting of ARCCNM & KSNM초록집 57(Supplement 2).
대한민국
(2023)
Prognostic significance of F-FDG PET/CT radiomics in patients with resectable pancreatic cancer undergoing curative surgery.
Annual Meeting of ARCCNM & KSNM초록집 57(Supplement 2).
대한민국
(2023)
Quantitative and semiquantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation.
Annual Meeting of ARCCNM & KSNM초록집 57(Supplement 2).
대한민국
(2022)
핵의학 신경내분비종양 치료 연구회, “SMC PRRT case review.
핵의학 신경내분비종양 치료 연구회.
대한민국
발전기금
